Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2024). On theSindex it has a DataRank of 0.290. It has been cited 5 times, with 1 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0.0217
From 1 citing papers with measurable signal
National Institutes of Health
Grant: 5R01DE028172-03
T cell plasticity, fusion proteins and CAR T cell-based immunotherapy of head and neck cancer
National Institutes of Health
Grant: 5K12CA087723-23
Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical Oncology
National Institutes of Health
Grant: 5R01CA226981-04
Prevention of post-therapy breast cancer metastasis
National Institutes of Health
Grant: 5K08CA226391-05
Ex Vivo Profiling of Immunotherapy Combinations Using Organotypic Tumor Spheroids
National Institutes of Health
Grant: 5K08CA234458-06
Dissecting Therapeutic Resistance and Progression in Metastatic Melanoma Through Clinical Computational Oncology
Fields of Study
Keywords
Sustainable Development Goals